Form D · Other
Wavely Diagnostics, Inc.
Seattle, WA · CIK 0001941569
Offering snapshot reported Aug 8, 2022 · SEC filing
- Reported sold
- $258K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2022 | Initial | $257,500 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-455210
Source: Form D, filed Aug 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Randall Bly | Director, Promoter |
| Naomi Fried | Director |
| Ehud Gelblum | Executive |
| Shyamnath Gollakota | Director, Promoter |
| Jud Heugel | Executive |
| Missy Krasner | Director |
| Arna Ionescu Stoll | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
2311 N 45 Th Street #207
Seattle, WA, 98103
Seattle, WA, 98103